Link Biotech offers a comprehensive range of high-quality biosimilar antibodies designed to deliver reliable performance at a cost-effective price. Our biosimilar antibodies are developed to closely match the reference antibodies in terms of specificity, affinity, and functional activity, ensuring consistent and reproducible results in research applications.
-
EGFR Antibody (Panitumumab biosimilar)
[wpdatatable id=339] -
NGF Antibody (Tanezumab Biosimilar)
[wpdatatable id=341] -
RGMA Antibody (Elezanumab Biosimilar)
[wpdatatable id=343] -
Sclerostin Antibody (Setrusumab biosimilar)
[wpdatatable id=337] -
TNF-Alpha Antibody (Infliximab Biosimilar)
[wpdatatable id=31]